LINDSEY HUCKBODY: Open Payments
NPI 1831369214 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,163 in 33 payments from 12 companies in 2025. Trend: 2023 $420 · 2024 $321 · 2025 $1,163
Food & beverage: $1,063Education: $100
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 4 | $210 |
| Merck Sharp & Dohme LLC | 8 | $182 |
| Astellas Pharma US Inc | 4 | $164 |
| Medical Device Business Services, Inc. | 1 | $125 |
| PFIZER INC. | 1 | $118 |
| AstraZeneca Pharmaceuticals LP | 5 | $116 |
| ABBVIE INC. | 3 | $67 |
| Genmab U.S., Inc. | 2 | $56 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Ethicon US, LLC | 1 | $33 |
Products named: LYNPARZA, Lenvima, VISTASEAL, ELREXFIO, KEYTRUDA, Veozah, Tivdak, ELAHERE.
Industry payments across NC — which companies pay providers there.
